Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 152 Show results per page	View Search Criteria \| Help With Results


1.		Phase II/III Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				Protocol CDX110-003 NCT00458601

Last Modified: 10/16/2008 First Published: 3/13/2006


2.		Phase III Randomized Study of Adjuvant Radiation Therapy and Conventional Temozolomide Versus Dose-Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI				RTOG-0525 RTOG-0525, EORTC-26052, EORTC-22053, NCT00304031


3.		Effect of NovoTTF-100A in Recurrent GBM

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Pharmaceutical / Industry				EF-11 NCT00379470


4.		Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-Tenascin Radiolabeled Antibody Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Pharmaceutical / Industry				BRAD-301 NCT00615186

Last Modified: 6/7/2007 First Published: 5/23/2005


5.		Phase I/II Study of Erlotinib and Temsirolimus in Patients With Recurrent Malignant Glioma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				NCI				NABTC-0402 NCI-06-C-0053, NABTC-04-02, NCT00112736

Last Modified: 10/5/2007 First Published: 7/22/2005


6.		A Phase I/II Study of Erlotinib and Radiotherapy in Young Patients With Newly Diagnosed Intracranial High-Grade Glioma or Unfavorable Low-Grade Glioma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				3 to 25				NCI, Pharmaceutical / Industry				SJCRH-SJHG04 GENENTECH-OSI3160s, NCT00124657


7.		A Phase I/II Study of the Photon Radiosurgery System

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				2 to 32				Other				CNS 0201 NCT00179907

Last Modified: 10/26/2007 First Published: 2/10/2006


8.		Phase I/II Study of GP96 Heat Shock Protein-Peptide Complex Vaccine in Patients With Recurrent or Progressive High-Grade Glioma (Phase I Study Closed to Accrual as of 7/25/2007)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				NCI				UCSF-05103 05103, UCSF-H41995-27311-01, NCT00293423

Last Modified: 2/21/2007 First Published: 2/10/2006


9.		Phase I/II Study of ZD6474 in Patients With Recurrent High-Grade or Progressive Low-Grade Gliomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				NCI				NCI-06-C-0063 NCI-P6680, NCT00293566

Last Modified: 10/22/2008 First Published: 3/17/2006


10.		Phase I/II Study of Motexafin Gadolinium Given Concurrently With Temozolomide and Fractionated Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme or Gliosarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				NCI				RTOG-0513 RTOG-0513, NCT00305864

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute